输血医学针对新型冠状病毒肺炎的治疗策略:临床进展与前景

Transfusion therapy against COVID-19 and its clinical advances

目前,新型冠状病毒肺炎(COVID-19)全世界确诊病例数持续增多。然而,其治疗的特效药和疫苗均尚处于研发阶段。输血医学作为临床医学的二级学科,一直以来在临床治疗中都发挥重要作用。输血治疗,如细胞治疗等或许可成为COVID-19患者,尤其是重症和危重症患者的选择之一。本文简要探讨了输血医学针对COVID-19的治疗策略,以期最大程度发挥输血医学的价值。

Currently, confirmed cases of COVID-19 worldwide continues to increase. However, the specific drugs and vaccines are still under development. As the secondary discipline of clinical medicine, transfusion medicine has always played an important role in clinical treatment. Blood transfusion therapy, including cell therapy, may be one of the options for COVID-19 patients, especially for severe and critically ill patients. In this paper, transfusion therapy against COVID-19 was briefly discussed, in order to maximize the value of blood transfusion medicine and present a new insight in potential therapeutic approaches.